/Viatris%20Inc%20logo%20on%20building-by%20SSKH-Pictures%20via%20Shutterstock.jpg)
Viatris Inc. (VTRS), valued at a market cap of $14.6 billion, is a global pharmaceutical and healthcare company formed in November 2020. Headquartered in Canonsburg, Pennsylvania, it develops, manufactures and distributes a broad portfolio of generic, branded, complex generic and biosimilar medicines across more than 165 countries and territories, supplying high-quality medicines to roughly 1 billion patients globally each year.
The global healthcare giant is expected to announce its fiscal 2025 fourth-quarter earnings soon. Ahead of the event, analysts expect VTRS to report a profit of $0.53 per share on a diluted basis, down 1.9% from $0.54 per share in the year-ago quarter. The company beat the consensus estimates in three of the last four quarters while missing the forecast on another occasion.